Paasa Logo
Heron Therapeutics, Inc. logo
HRTXNASDAQMarket openCloses 4:00pm ET

Heron Therapeutics, Inc.

$0.30Last updated
+$0.01 (3.21%)Past day
Timezone

Heron Therapeutics, Inc. (NASDAQ: HRTX) is trading at $0.30, about ₹29 at today's USD/INR rate, as of 25 Sep 2026, 2:58 PM ET, up 3.21% today. Indian residents can buy Heron Therapeutics from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$0.29
Previous close:$0.29
Volume:1.09M

Today's low

$0.28

Today's high

$0.30

52 week low

$0.26

52 week high

$1.58

HRTX opened at $0.29, closed previously at $0.29, and has traded between $0.26 and $1.58 over the past 52 weeks.

About

Heron Therapeutics, Inc. is a biotechnology firm dedicated to creating innovative therapies for critical patient requirements. The company leverages its proprietary Biochronomer drug delivery platform, an advanced system that enables the controlled release of various short-acting pharmacological agents. This technology ensures therapeutic concentrations are maintained for periods ranging from days to weeks following just a single administration. Among its commercialized products is SUSTOL (granisetron), an extended-release injectable designed to prevent both immediate and delayed nausea and vomiting triggered by moderately emetogenic chemotherapy, or specific anthracycline and cyclophosphamide combination therapies. Additionally, Heron markets CINVANTI, an intravenous formulation of aprepitant. CINVANTI, which acts as a substance P/neurokinin-1 receptor antagonist, is indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients undergoing highly or moderately emetogenic cancer chemotherapy. The company's development pipeline includes ZYNRELEF, an innovative dual-acting local anesthetic that combines bupivacaine, a local anesthetic, with a low dose of the nonsteroidal anti-inflammatory drug (NSAID) meloxicam in a single fixed-dose formulation. Also in development is HTX-019, an experimental therapy aimed at preventing postoperative nausea and vomiting (PONV). Furthermore, HTX-034 is being advanced for postoperative pain management and is currently undergoing Phase Ib/II clinical trials, notably in patients recovering from bunionectomy procedures. Originally established in 1983 as A.P. Pharma, Inc., the company adopted its current name, Heron Therapeutics, Inc., in January 2014. Its corporate headquarters are situated in San Diego, California.

Country
US
CEO
Craig Alexander Collard
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
128
Sector
Healthcare
IPO date
26/08/1987

Key statistics

Avg. volume

3.09M

Market cap

$56.65M

P/E Ratio

-1.60

Price-to-sales ratio

0.37

Enterprise value

$184.28M

Free cash flow yield

-21.42%

Debt-to-equity ratio

21.48

Return on equity

-300.90%

ROIC

-6.78%

Beta

1.61

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$154.90M

Earnings per share

-$0.12

Free cash flow

-$27.91M

Net profit margin

-22.52%

Gross margin

70.07%

EBITDA

-$17.88M

Revenue growth

7.36%

Similar securities

This is not an investment recommendation

How to buy Heron Therapeutics from India

Indian residents can buy Heron Therapeutics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Heron Therapeutics and place an order

    Find Heron Therapeutics by name or by its ticker, HRTX, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Heron Therapeutics trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Heron Therapeutics position in USD and INR. Heron Therapeutics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Heron Therapeutics from India

Trading and taxes when buying Heron Therapeutics from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneHeron Therapeutics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Heron Therapeutics stock?

Yes. Heron Therapeutics (HRTX) has been listed on NASDAQ since 1987, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Heron Therapeutics share cost in rupees?

One Heron Therapeutics share is $0.30 — about ₹29 at a USD/INR rate of 96.02 on 24 Sep 2026. Both the Heron Therapeutics price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Heron Therapeutics from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Heron Therapeutics?

Yes. One Heron Therapeutics share is $0.30, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Heron Therapeutics.

How are gains on Heron Therapeutics shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Heron Therapeutics price. Paasa issues a capital-gains statement for your return.

Does Heron Therapeutics pay a dividend?

No. Heron Therapeutics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Heron Therapeutics from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Heron Therapeutics shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare Heron Therapeutics shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Heron Therapeutics holding, its cost and its closing value.

How do I sell Heron Therapeutics and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.